EichorEICHOR
Study identifier: NCT02782663 Synced from ClinicalTrials.gov · August 06, 2026
● Study status: Completed

A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease

Condition: Crohn's Disease (CD)  ·  Sponsor: AbbVie

PhasePhase 2
Planned participants107
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This is a open-label extension (OLE) study designed to evaluate the long-term efficacy, safety, and tolerability of Upadacitinib (ABT-494).

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (61)

UC San Diego Health System /ID# 150041La Jolla, California, United States
Univ California, San Francisco /ID# 149987San Francisco, California, United States
Duplicate_University of Florida - Archer /ID# 150033Gainesville, Florida, United States
The Ctr for Gastro Disorders /ID# 150012Hollywood, Florida, United States
Nature Coast Clinical Research - Inverness /ID# 149975Inverness, Florida, United States
Gastroenterology Associates of Central Georgia, LLC /ID# 149870Macon, Georgia, United States
GI Specialists of GA, PC /ID# 150015Marietta, Georgia, United States
Cotton O'Neil Clinical Research Center, Digestive Health /ID# 149900Topeka, Kansas, United States
Duplicate_University of Louisville /ID# 149884Louisville, Kentucky, United States
Investigative Clinical Research /ID# 149886Annapolis, Maryland, United States
Charm City Research Group /ID# 150040Towson, Maryland, United States
Clin Res Inst of Michigan, LLC /ID# 150008Chesterfield, Michigan, United States

+ 49 more locations — full list on the registry record.

Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →